KAT General Hospital
10
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
80.0%
-6.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb® in Hand Surgery
Role: collaborator
Reliability and Validity of the IASP Clinical Criteria for Identifying Patients with Nociplastic Pain
Role: collaborator
Morphine Versus Ketamine as Adjuvants in Paravertebral Blocks
Role: collaborator
Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture
Role: collaborator
The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA
Role: collaborator
Central Sensitization Symptoms and Psychosocial Factors in Athletes After ACL Reconstruction
Role: collaborator
Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.
Role: lead
Evaluation of Dexketoprofen in Total Knee Arthroplasty
Role: lead
Cognitive Behavioral Factors and Central Sensitization in Chronic Shoulder Pain
Role: collaborator
Dexmetomidine Intrathecally and Intravenously Additionally to Spinal Anaesthesia, in Total Knee Arthroplasty
Role: lead
All 10 trials loaded